Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Thrombocythemia, Essential 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pheochromocytoma 1Melanoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Hyperaldosteronism 1Endocrine Gland Neoplasms 1Congenital Abnormalities 1Colorectal Neoplasms 1Anemia, Refractory, with Excess of Blasts 1ACTH Syndrome, Ectopic 1

Interventions

Radiofrequency Ablation 2ziprasidone 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tranexamic Acid 1Tobramycin 1Staining and Labeling 1Spironolactone 1Sevelamer 1Rocuronium 1Prednisone 1Piperacillin, Tazobactam Drug Combination 1Pentobarbital 1Oxycodone 1Observation 1Nifedipine 1Nafcillin 1Molindone 1Methylprednisolone 1Lurasidone Hydrochloride 1Labetalol 1Haloperidol 1Fosfomycin 1Dexamethasone 1Clozapine 1Ciprofloxacin 1Cidofovir 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperaldosteronism × Staining and Labeling × Clear all
NCT05446779 2024-04-16

SuddenDeath

Helsinki University Central Hospital

Active not recruiting
400 enrolled
Endocrine

ACTH Syndrome, Ectopic, Endocrine Gland Neoplasms, Hyperaldosteronism, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡